lobbying_activities: 2769798

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2769798	de183a04-4be8-46a4-862c-ee3a87334f5c	Q1	CRISPR THERAPEUTICS, INC.	401105184	CRISPR THERAPEUTICS, INC.	2022	first_quarter	HCR	General issues related to reimbursement and FDA regulatory pathways for cell and gene therapies.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE		60000	0	0	2022-04-04T14:39:16-04:00